These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 28456775)
1. Atrial natriuretic peptide and brain natriuretic peptide changes after epicardial percutaneous left atrial appendage suture ligation using LARIAT device. Bartus K; Podolec J; Lee RJ; Kapelak B; Sadowski J; Bartus M; Oles K; Ceranowicz P; Trabka R; Litwinowicz R J Physiol Pharmacol; 2017 Feb; 68(1):117-123. PubMed ID: 28456775 [TBL] [Abstract][Full Text] [Related]
2. Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage With the Watchman Device. Majunke N; Sandri M; Adams V; Daehnert I; Mangner N; Schuler G; Moebius-Winkler S J Invasive Cardiol; 2015 Oct; 27(10):448-52. PubMed ID: 25999139 [TBL] [Abstract][Full Text] [Related]
3. The role of multimodality imaging in percutaneous left atrial appendage suture ligation with the LARIAT device. Laura DM; Chinitz LA; Aizer A; Holmes DS; Benenstein R; Freedberg RS; Kim EE; Saric M J Am Soc Echocardiogr; 2014 Jul; 27(7):699-708. PubMed ID: 24874974 [TBL] [Abstract][Full Text] [Related]
4. Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device. Maybrook R; Pillarisetti J; Yarlagadda V; Gunda S; Sridhar AR; Deibert B; Afzal MR; Reddy M; Atkins D; Earnest M; Ferrell R; Nath J; Kanmanthareddy A; Bommana S; Johnson R; Koripalli SR; Dawn B; Lakkireddy D J Interv Card Electrophysiol; 2015 Sep; 43(3):245-51. PubMed ID: 25956479 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. Bartus K; Han FT; Bednarek J; Myc J; Kapelak B; Sadowski J; Lelakowski J; Bartus S; Yakubov SJ; Lee RJ J Am Coll Cardiol; 2013 Jul; 62(2):108-118. PubMed ID: 23062528 [TBL] [Abstract][Full Text] [Related]
6. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage. Luani B; Rauwolf T; Groscheck T; Tanev I; Herold J; Isermann B; Schmeisser A; Braun-Dullaeus RC Heart Lung Circ; 2018 Jul; 27(7):828-834. PubMed ID: 28818408 [TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of compassionate use of LARIAT® device for epicardial ligation of anatomically complex left atrial appendages. Patel MB; Rasekh A; Shuraih M; Chelu MG; Bartlett T; Mathuria N; Naeini P; Strickland J; Massumi A; Razavi M; Cheng J J Interv Card Electrophysiol; 2015 Jan; 42(1):11-9. PubMed ID: 25595627 [TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide levels variation after left atrial appendage occlusion. Cruz-Gonzalez I; Palazuelos Molinero J; Valenzuela M; Rada I; Perez-Rivera JA; Arribas Jimenez A; Gabella T; Prieto AB; Martín Polo J; Sánchez PL Catheter Cardiovasc Interv; 2016 Jan; 87(1):E39-43. PubMed ID: 26033157 [TBL] [Abstract][Full Text] [Related]
9. Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device. Miller MA; Gangireddy SR; Doshi SK; Aryana A; Koruth JS; Sennhauser S; d'Avila A; Dukkipati SR; Neuzil P; Reddy VY Heart Rhythm; 2014 Nov; 11(11):1853-9. PubMed ID: 25068574 [TBL] [Abstract][Full Text] [Related]
10. Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study). Parikh V; Rasekh A; Mohanty S; Yarlagadda B; Atkins D; Bommana S; Turagam M; Jeffery C; Carroll H; Nydegger C; Jaeger M; Dar T; Cheng J; Gopinnathanair R; Dibiase L; Lee R; Horton R; Natale A; Lakkireddy D J Interv Card Electrophysiol; 2020 Apr; 57(3):409-416. PubMed ID: 31863251 [TBL] [Abstract][Full Text] [Related]
11. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Afzal MR; Kanmanthareddy A; Earnest M; Reddy M; Atkins D; Bommana S; Bartus K; Rasekh A; Han F; Badhwar N; Cheng J; Dibiase L; Ellis CR; Dawn B; Natale A; Lee RJ; Lakkireddy D Heart Rhythm; 2015 Jan; 12(1):52-9. PubMed ID: 25281005 [TBL] [Abstract][Full Text] [Related]
12. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation. Bakowski D; Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248 [TBL] [Abstract][Full Text] [Related]
13. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation. Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125 [TBL] [Abstract][Full Text] [Related]
14. A collective European experience with left atrial appendage suture ligation using the LARIAT+ device. Tilz RR; Fink T; Bartus K; Wong T; Vogler J; Nentwich K; Panniker S; Fang Q; Piorkowski C; Liosis S; Gaspar T; Sawan N; Metzner A; Nietlispach F; Maisano F; Lee RJ; Foran JP; Ouyang F; Sievert H; Deneke T; Kuck KH Europace; 2020 Jun; 22(6):924-931. PubMed ID: 32044994 [TBL] [Abstract][Full Text] [Related]
15. Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function. Harada M; Tabako S; Fujii Y; Takarada Y; Hayashi K; Ohara H; Hara F; Ikeda T J Echocardiogr; 2018 Jun; 16(2):72-80. PubMed ID: 29256043 [TBL] [Abstract][Full Text] [Related]
16. Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS Study. Lakkireddy D; Turagam M; Afzal MR; Rajasingh J; Atkins D; Dawn B; Di Biase L; Bartus K; Kar S; Natale A; Holmes DJ J Am Coll Cardiol; 2018 Jan; 71(2):135-144. PubMed ID: 29325636 [TBL] [Abstract][Full Text] [Related]
17. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation. Ramlawi B; Abu Saleh WK; Edgerton J Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127 [TBL] [Abstract][Full Text] [Related]
18. Influence of Left Atrial Appendage Amputation on Natriuretic Peptides-A Randomized Controlled Trial. Grieshaber P; Arneth B; Steinsberger F; Niemann B; Oswald I; Renz H; Böning A Thorac Cardiovasc Surg; 2021 Mar; 69(2):117-123. PubMed ID: 30929250 [TBL] [Abstract][Full Text] [Related]
19. Left Atrial Appendage Remodeling After Lariat Left Atrial Appendage Ligation. Kreidieh B; Rojas F; Schurmann P; Dave AS; Kashani A; Rodríguez-Mañero M; Valderrábano M Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1351-8. PubMed ID: 26486856 [TBL] [Abstract][Full Text] [Related]
20. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Igarashi Y; Kashimura K; Makiyama Y; Sato T; Ojima K; Aizawa Y Jpn Circ J; 2001 Sep; 65(9):788-92. PubMed ID: 11548877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]